Urogut

Used in Urogut to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia.

The most common disorder of the prostate gland is benign prostatic hyperplasia (BPH), or the enlargement of the prostate. It is thought that BPH is caused by an accumulation of testosterone (a potent male hormone) in the prostate. Testosterone is converted to DHT (a more potent hormone), which stimulates the increase in the cells that cause the prostate to enlarge.
Urogut prevents and treats BPH by interfering with the process of testosterone metabolism that may be involved in causing the enlargement of the prostate. Urogut may also improve urinary flow rates.